Small Molecules
28 March 2017
Kadmon Presents Preclinical Data Supporting the Therapeutic Potential of ROCK Inhibition in Pulmonary Fibrosis28 March 2017
Tesaro announces U.S. FDA approval of Zejula™ (niraparib) for women with recurrent ovarian cancer27 March 2017
Newron presents encouraging detailed results of its Phase IIa study with Evenamide in patients with schizophrenia23 March 2017
Ultragenyx Announces Topline Data from Phase 2 UX007 Glucose Transporter Type-1 Deficiency Syndrome Seizure Study22 March 2017
Cytokinetics Announces Preclinical Data for CK-2127107 Presented at MDA Scientific Conference22 March 2017
AVEO Announces First Patient Dosed in Phase 1/2 TiNivo Trial of Tivozanib and Opdivo® (nivolumab) in Advanced RCC21 March 2017
Blueprint Medicines Announces Enrollment of First Patient in Phase 1 Clinical Trial for BLU-66720 March 2017
Opiant Pharmaceuticals, Inc. Announces Initiation of Phase 2 Clinical Trial Evaluating OPNT001 in Bulimia NervosaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports